EcoDrugPlus

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSSTUG00000029215
Gene Symbol: LOC115176186
3 Cross references
180 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSSTUG00000024038
Gene Symbol: LOC115199102
3 Cross references
220 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSSTUG00000033393
Gene Symbol: LOC115180504
3 Cross references
215 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-2-Like

Ensembl ID : ENSSTUG00000048584
Gene Symbol: LOC115150944
3 Cross references
199 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-2-Like

Ensembl ID : ENSSTUG00000025927
Gene Symbol: LOC115207482
3 Cross references
201 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-4-Like

Ensembl ID : ENSSTUG00000015707
Gene Symbol: LOC115192701
2 Cross references
228 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-4-Like

Ensembl ID : ENSSTUG00000029084
Gene Symbol: LOC115189934
2 Cross references
233 Possible Orthologues:

Wee1-Like Protein Kinase 1-A

Ensembl ID : ENSSTUG00000020466
Gene Symbol: LOC115197066
3 Cross references
199 Possible Orthologues:

Wee1-Like Protein Kinase 1-A

Ensembl ID : ENSSTUG00000027444
Gene Symbol: LOC115192812
3 Cross references
199 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSSTUG00000019052
Gene Symbol: XDH
3 Cross references
210 Possible Orthologues:

Ensembl ID : ENSSTUG00000026900
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSSTUG00000014690
Gene Symbol: -
Cross references: -
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).